Profile

Christopher Y. Thomas, M.D.Wake Forest Baptist Health

Doctor Rating

4.7 out of 5

165 Ratings
14 Comments
 

Christopher Y. Thomas, M.D.

Associate Professor,

Clinical Interests

Genitourinary Cancer, Bladder Cancer, Prostate Cancer, Genitourinary Oncology

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-713-5440
Department: 336-716-4464

Insurance Accepted »

Education & Training

  • A.B., University of Kansas, 1970
  • M.D., University of Kansas, 1974
  • Residency, Internal Medicine, Cincinnati General Hosp, 1977
  • Fellowship, Hematology And Oncology, University of Cincinnati, 1978
  • Fellowship, Hematology And Oncology, Tufts University School of Med, 1979
  • Fellowship, Molecular Genetics, Tufts University School of Med, 1981

Board Certifications

  • American Board of Internal Medicine, Hematology
  • American Board of Internal Medicine, Internal Medicine
  • American Board of Internal Medicine, Medical Oncology

NPI Number

  • 1942370119
Christopher Y. Thomas, M.D.

Doctor Rating

4.7 out of 5

165 Ratings
14 Comments
 

Christopher Y. Thomas, M.D.

Associate Professor, Hematology & Oncology
Urology

Research Interests

Proto-Oncogenes; DNA Copy Number Variations; Genetic Markers; Prostatectomy; Genes, p16
More »

Contact Information

Academic: 434-243-6356 | Department: 336-716-4464

Recent Publications

Adenoid cystic carcinoma: a review of recent advances, molecular targets, and clinical trials. Dillon PM, Chakraborty S, Moskaluk CA, Joshi PJ, Thomas CY.. Head Neck. 2016;38(4):620-627.

A phase II study of dovitinib in patients with recurrent or metastatic adenoid cystic carcinoma (ACC) [abstract]. Dillon PM, Petroni GR, Moskaluk C, Fracasso PM, Douvas MG, Perez JR, Varhegyi N, Zaja-Milatovic S, Thomas CY.. J Clin Oncol. 2015;33(15 Suppl):e17092.

A theory-based decision aid for patients with cancer: results of feasibility and acceptability testing of DecisionKEYS for cancer. Hollen PJ, Gralla RJ, Jones RA, Thomas CY, Brenin DR, Weiss GR, Schroen AT, Petroni GR.. Support Care Cancer. 2013;21(3):889-899.

Phase II study of dovitinib (TK1258) in patients with progressive metastatic adenoid cystic carcinoma [abstract]. Dillon PM, Moskaluk C, Fracasso PM, Petroni GR, Thomas CY.. J Clin Oncol. 2013;31(15 Suppl):6021.

Randomized phase II trial of cixutumumab (CIX) alone or with cetuximab (CET) for refractory recurrent/metastatic squamous cancer of head and neck (R/M-SCCHN) [abstract]. Glisson BS, Tseng J, Marur S, Shin DM, Murphy BA, Cohen EEW, Thomas CY, Willey R, Cosaert J, William WN, Harun N, Lee JJ, Haddad RI.. J Clin Oncol. 2013;31(15 Suppl):6030.

Genetic markers associated with early cancer-specific mortality following prostatectomy. Liu W, Xie CC, Thomas CY, Kim ST, Lindberg J, Egevad L, Wang Z, Zhang Z, Sun J, Sun J, Koty PP, Kader AK, Cramer SD, Bova GS, Zheng SL, Gronberg H, Isaacs WB, Xu J.. Cancer. 2013;119(13):2405-2412.

Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy. Thomas CY, Hemal AK.. BJU Int. 2013;112(4):425-426.

p16, Cyclin D1, and HIF-1alpha predict outcomes of patients with oropharyngeal squamous cell carcinoma treated with definitive intensity-modulated radiation therapy. Rahimi AS, Wilson DD, Saylor DK, Stelow EB, Thomas CY, Reibel JF, Levine PA, Shonka DC, Jameson MJ, Read PW.. Int J Otolaryngol. 2012;2012():685951.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Associate Professor, Hematology & Oncology

Clinical Interests

Genitourinary Cancer, Bladder Cancer, Prostate Cancer, Genitourinary Oncology
Christopher Y. Thomas, M.D.

Christopher Y. Thomas, M.D.

Associate Professor, Hematology & Oncology
Urology

Doctor Rating

4.7 out of 5

Christopher Y. Thomas, M.D.165 Ratings
14 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.8
CP efforts to include in decisions
4.8
CP explanations of prob/condition
4.8
CP spoke using clear language
4.8
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.7
Patients' confidence in CP
4.8
Time CP spent with patient
4.7
Wait time at clinic
4.0



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

7/25/2016

Dr. Thomas is a wonderful care provider: professional, patient and concerned. I appreciate his time and his kind manner.

7/22/2016

Everything is always very good in my care from *Dr. Thomas.

7/21/2016

*Dr. Thomas gave complete answers to questions.

7/12/2016

A model for all care givers.

5/25/2016

Keeps me well informed/asks about my thoughts and understanding of his explanations/is will to answer my questions.

5/20/2016

Dr. Thomas and his staff is very caring

4/25/2016

My son was calm when we left and seemed happy with the message he got from this provider.

4/25/2016

I would recommend *Dr. Thomas with anyone with same problem I have.

4/8/2016

Very, very pleased to be a patient of *Dr. Thomas.

3/8/2016

Dr. Thomas was very kind and took time to explain things to us and let us ask questions.

2/9/2016

Very timely with help!

1/14/2016

Compassion and caring.

1/7/2016

Good; if they have cancer.

12/19/2015

Dr. Thomas is a wonderful, professional cancer doctor. I would recommend others to him if they needed a cancer doctor.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Comprehensive Cancer Centers National Designation is RenewedMagnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.